MENU
SPRO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Spero Therapeutics (SPRO) Ownership - Who owns Spero Therapeutics?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
46
Web
https://www.sperotherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
56.43M
P/E Ratio
12.94
Total Cash
76.29M
Projected Growth
N/A
Total Debt
4.62M
Revenue
89.87M
Risk (Beta)
0.08
Dividend Yield
N/A
Total Cash/Share
1.40
Total Debt/Equity
N/A
Revenue/Share
1.67 USD as % of share price
Fundamentals
SPRO
Capitalization
56.4M
P/E Ratio
12.94
Risk (Beta)
0.08
Dividend Yield
N/A
Total Cash
76.3M
Total Cash/Share
1.40
Total Debt
4.62M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.67%
Revenue
89.9M
ROE
N/A
Book Value
65.5M
P/B Ratio
0.86
Cash Flow
N/A
Earnings
0.08
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
54K
Current Ratio
2.68
Current Revenue Per Employee
169978.27
Dividends Per Share - Security
N/A
EBITDA
-2.45M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
2.90
Shares Held By Institutions
18.8M
Shares Outstanding - Current
54.5M
Total Liabilities
69.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-29.592
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel therapies for the treatment of resistant bacterial infections
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
46
Web
https://www.sperotherapeutics.com